Drug Search Results
More Filters [+]

Tucaresol

Alternative Names: tucaresol
Latest Update: 2008-10-13
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: TH2 Enhancer

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: GlaxoSmithKline
Company Location: BRENTFORD MIDDLESEX X0 TW8 9GS
Company CEO: Emma Walmsley
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tucaresol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: HIV Infections

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT00343941

P2

Completed

HIV Infections

None

311A

P1

Unknown status

HIV Infections

None

Recent News Events

Date

Type

Title